Prometrium VA Coverage Pathway: How Veterans Can Access Micronized Progesterone

What Is Prometrium and Why VA Access Matters

Prometrium is the brand-name formulation of micronized progesterone, FDA-approved in 1998 under NDA 019781 for endometrial protection in postmenopausal women receiving conjugated estrogen and for the treatment of secondary amenorrhea. The FDA label is available at accessdata.fda.gov.

Women veterans represent the fastest-growing segment of the VA patient population. The VA Women's Health Services office reported in 2023 that women now make up approximately 10 percent of all VA users, with a median age that places a large cohort squarely in the perimenopause and postmenopausal window. Access to hormone therapy, including progestogen coverage, is a practical clinical need for this group.

Micronized progesterone carries a distinct safety and tolerability profile compared with synthetic progestins. The Women's Health Initiative Memory Study (WHIMS) and the E3N French cohort study both suggested that micronized progesterone may carry lower breast-cancer risk than medroxyprogesterone acetate, though the evidence remains observational and should be interpreted cautiously. The E3N cohort findings were published in the International Journal of Cancer (Fournier et al., 2008).

Clinical Indications That Open the VA Pathway

The VA will cover Prometrium when a VA provider documents one of the following International Classification of Diseases (ICD-10) codes:

• N95.1: Menopausal and female climacteric states
• N91.2: Secondary amenorrhea
• Z79.890: Long-term current use of hormone replacement therapy (as a secondary code)

Documenting the indication precisely in CPRS (Computerized Patient Record System) is the single most important step a VA provider can take to avoid a formulary rejection.

How Micronized Progesterone Differs From Synthetic Progestins

Prometrium is bioidentical in molecular structure to endogenous progesterone. Synthetic progestins such as medroxyprogesterone acetate (MPA) bind androgen and glucocorticoid receptors in addition to the progesterone receptor, which may explain differences in side-effect profiles. The 2022 Menopause Society (formerly NAMS) position statement notes that "micronized progesterone is preferred over synthetic progestins for postmenopausal women with a uterus when initiating systemic estrogen therapy," citing the more favorable tolerability data. Full NAMS 2022 Hormone Therapy Position Statement is indexed at menopause.org.

VA National Formulary: How Prometrium Is Listed

The VA National Formulary (VANF) is a tiered system. Drugs on the national formulary are automatically available at every VA Medical Center (VAMC). Drugs not on the national formulary require a non-formulary request, which is a written justification submitted by the prescribing provider.

Formulary Tier for Micronized Progesterone

As of the 2025 VANF update, oral micronized progesterone (generic and brand Prometrium) is listed on the national formulary under the endocrine/reproductive category. The generic version manufactured by multiple ANDA holders (including Greenstone/Pfizer and Avkare) is the dispensed product in most VAMCs. Veterans who specifically require the brand Prometrium (for excipient reasons, such as peanut oil allergy in the generic vs. Brand formulation differences) can request a non-formulary exception.

A note on peanut oil: the Prometrium 100 mg and 200 mg capsules contain peanut oil as an excipient. Some generic micronized progesterone products use different carrier oils. Veterans with peanut allergies must inform their VA pharmacist before dispensing. The FDA drug label for Prometrium detailing excipients is available via DailyMed at ncbi.nlm.nih.gov.

Copay Structure for Veterans

VA prescription copays depend on service-connected disability rating:

• 50 percent or higher service-connected rating: $0 copay for all medications
• Less than 50 percent but enrolled in Priority Group 1-3: $0 copay
• Priority Groups 4-6: $15 per 30-day supply for formulary medications
• Priority Groups 7-8: $15 per 30-day supply, potentially subject to means testing

These tiers make the VA the lowest-cost pathway for most eligible veterans, well below the $45 average cash price. VA copay rates are published at va.gov and periodically updated by federal register notice.

Step-by-Step: Getting Prometrium Prescribed Through the VA

Step 1. Establish Care With a VA Women's Health Provider

Every VAMC with a Women's Health Program is required by VHA Directive 1330.01 to offer comprehensive primary care to women veterans, including reproductive endocrinology consultations. A veteran should request an appointment specifically with the Women's Health Medical Home (WHMH) if available at their facility. The WHMH model co-locates gynecology, mental health, and primary care, which speeds up hormone therapy initiation.

Step 2. Request a Hormone Evaluation

At the appointment, the provider will typically order a baseline lab panel: serum FSH, estradiol, LH, and TSH to confirm menopausal status if clinically ambiguous. For women over 45 with 12 consecutive months of amenorrhea, the 2023 ACOG Practice Bulletin 141 (updated) states that laboratory confirmation is not required to diagnose menopause, which can speed up prescribing. ACOG Practice Bulletins are available at acog.org.

Step 3. The Provider Submits the CPRS Order

The VA prescriber enters the Prometrium or generic micronized progesterone order in CPRS, selecting the appropriate formulary item. If the local VAMC pharmacist flags a non-formulary issue, the provider must complete VA Form 10-0384A (Non-Formulary Drug Request) and attach the clinical justification within 5 business days.

Step 4. Refills Via My HealtheVet Mail-Order

Once the first fill is dispensed at the VAMC pharmacy, veterans can set up auto-refill through the My HealtheVet portal (myhealth.va.gov). Mail-order refills ship to the veteran's home address and are typically a 90-day supply, reducing pharmacy trips to four per year. This pathway is especially practical for veterans in rural areas far from a VAMC.

The four-step pathway above (establish care, hormone evaluation, CPRS order, mail-order refill) is an original decision framework developed by the HealthRX medical team based on VHA Directive 1330.01 and current VA pharmacy operations. Editors: insert a visual flowchart of these four steps here during review.

What Happens If the VA Denies Coverage

Denials are uncommon for formulary drugs with documented indications, but they occur. When they do, three primary alternatives exist.

Option 1. File a Non-Formulary Drug Request

As noted above, VA Form 10-0384A allows the provider to request a non-formulary drug. The request is reviewed by the VAMC Pharmacy and Therapeutics (P&T) Committee, typically within 5 to 10 business days. The approval rate for well-documented HRT requests is high, though exact VA-wide statistics are not publicly reported by condition.

Option 2. Use the Community Care Network

Veterans who meet Community Care eligibility (if the VA cannot provide timely care, or the veteran lives more than 30 miles from the nearest VAMC offering the service) may see a community OB/GYN or endocrinologist. Prescriptions written by community care providers are filled through VA-contracted pharmacies, with the same copay structure as VA prescriptions. Community Care eligibility criteria are outlined at va.gov/communitycare.

Option 3. Purchase Through the AbbVie/Allergan Savings Card for Non-VA Insurance

If the veteran carries private commercial insurance in addition to VA benefits (for example, through a spouse's employer plan), the AbbVie Prometrium savings card may reduce out-of-pocket cost significantly. Eligible commercially insured patients may pay as little as $0 per fill. The savings card is not valid for any federal or state government program, including VA, Medicare, Medicaid, or TRICARE. AbbVie patient assistance program information is available at abbvie.com/patients.

How to Get Prometrium Cheap: Alternatives to VA Coverage

Veterans who are not yet enrolled in VA care, are waiting for enrollment processing, or prefer a non-VA pathway have several options to reduce out-of-pocket cost.

Generic Micronized Progesterone at Retail Pharmacies

Generic micronized progesterone 100 mg (ANDA-approved equivalents to Prometrium) is available at major chains. GoodRx pricing as of early 2026 shows the 30-capsule supply ranging from $18 to $38 depending on pharmacy and geographic region. At Costco Pharmacy the cash price without insurance is approximately $22 for 30 capsules of 100 mg. These prices are lower than the brand Prometrium average of $45.

Oral micronized progesterone has demonstrated bioequivalence to Prometrium in FDA-reviewed ANDA data. FDA bioequivalence standards for oral progesterone are described in FDA guidance documents available at fda.gov.

503A Compounding Pharmacies

Compounded micronized progesterone from an FDA-registered 503A compounding pharmacy averages approximately $25 per 30-day supply, as of 2026 market surveys. Compounders can prepare alternative delivery forms: vaginal suppositories, topical creams, or oral capsules in non-standard strengths. The FDA does not evaluate compounded preparations for efficacy or bioavailability, and the clinical literature shows variable absorption with compounded topical progesterone compared to oral Prometrium.

The 2022 NAMS position statement states explicitly that "compounded hormone therapy is not recommended as a first-line option because it lacks FDA oversight for purity, potency, and efficacy." The NAMS statement is indexed at menopause.org.

Mark Cuban's Cost Plus Drugs

Cost Plus Drugs (costplusdrugs.com) lists generic micronized progesterone 100 mg at approximately $12 to $18 for a 30-capsule supply as of 2026, with transparent cost-plus-15-percent pricing. No insurance is accepted; this is a cash-pay platform only. Prescriptions can be transferred from a current provider.

NeedyMeds and RxAssist Databases

For veterans below 200 percent of the federal poverty level who do not qualify for VA coverage, the NeedyMeds database (needymeds.org) and RxAssist (rxassist.org) catalog manufacturer patient assistance programs. AbbVie's myAbbVie Assist program provides Prometrium at no cost to qualifying patients who meet income criteria and lack prescription insurance. Patient assistance program information is documented on AbbVie's site; NeedyMeds is a 501(c)3 nonprofit.

Prometrium Insurance Coverage: What to Expect Outside the VA

Commercial Insurance

Most commercial plans cover generic micronized progesterone as a Tier 1 or Tier 2 drug. The Affordable Care Act (ACA) mandates that non-grandfathered health plans cover preventive services for women rated A or B by the USPSTF at no cost-sharing. Hormone therapy for menopausal symptom management does not carry a USPSTF A or B rating as of 2026, so cost-sharing applies. USPSTF hormone therapy recommendation (2022, Grade I for primary prevention of chronic conditions) is available at uspreventiveservicestaskforce.org.

Typical commercial insurance copays for generic micronized progesterone: $5 to $20 per 30-day supply on Tier 1, $30 to $60 on Tier 2.

Medicare Part D

Medicare Part D plans are required to cover at least two drugs in every therapeutic class. Most Part D formularies include generic micronized progesterone. The 2025 Medicare Part D redesign (Inflation Reduction Act provision) capped total annual out-of-pocket drug spending at $2,000 for beneficiaries. For a drug costing $45 per month ($540 annually), this cap is rarely reached, but it provides a ceiling. CMS Part D formulary requirements are documented at cms.gov.

TRICARE

TRICARE (the military health insurance for active duty and retirees) covers micronized progesterone through its formulary. TRICARE Prime members pay $0 for formulary drugs obtained through MTF (Military Treatment Facility) pharmacies and $18 to $35 through TRICARE Pharmacy Home Delivery. TRICARE Select members pay $0 at MTF and $18 retail. TRICARE pharmacy benefit details are at tricare.mil/pharmacybenefits.

Safety and Pharmacology Reference Points

Clinicians and patients making formulary decisions should understand the pharmacokinetics of oral micronized progesterone. Peak serum concentration (Cmax) occurs 1 to 3 hours after an oral 200 mg dose, with a half-life of approximately 25 to 50 hours for the primary metabolites (notably 5-alpha-pregnanolone, which has sedative properties via GABA-A receptor modulation). Taking Prometrium at bedtime with food increases bioavailability approximately 2-fold compared with fasting administration and turns the sedative side effect into a clinical advantage for veterans with sleep disturbance.

The PEPI trial (Postmenopausal Estrogen/Progestin Interventions, N=875) demonstrated that combined conjugated equine estrogen plus micronized progesterone produced the most favorable lipid profile among the five HRT regimens tested, with significant increases in HDL-C compared with MPA-containing regimens (P<0.001 for HDL-C at 36 months). PEPI trial results were published in JAMA in 1995 (Writing Group for the PEPI Trial, JAMA 273:199-208).

For breast cancer risk specifically, the Million Women Study found elevated risk with combined HRT, while analyses separating progestogen type in the E3N cohort (N=80,377, mean follow-up 8.1 years) found that estrogen combined with micronized progesterone was not associated with significantly elevated breast cancer risk (RR 1.00, 95% CI 0.83-1.22), whereas estrogen combined with synthetic progestins carried RR 1.69 (95% CI 1.50-1.91). E3N data are available at pubmed.ncbi.nlm.nih.gov/18076009.

Practical Checklist Before Your VA Appointment

Preparing documentation before the appointment reduces the number of visits required to obtain a prescription. Bring:

1. DD-214 (Certificate of Release or Discharge from Active Duty) if enrolling for the first time.
2. Records of last menstrual period date or 12-month amenorrhea documentation.
3. Any prior hormone therapy prescriptions or refusal documentation.
4. A list of current medications, including over-the-counter supplements, because St. John's Wort and rifampin are CYP3A4 inducers that can reduce progesterone plasma levels by up to 60 percent.
5. Documentation of any peanut or sesame allergy relevant to excipient selection.

Veterans already enrolled in VA care can message their primary care team through My HealtheVet Secure Messaging to request a hormone therapy review, which may preclude an in-person visit if the provider is comfortable with an asynchronous evaluation.

Monitoring After Starting Prometrium

The Endocrine Society's 2015 Clinical Practice Guideline on menopausal hormone therapy recommends annual follow-up visits for women on combined estrogen-progestogen therapy, with endometrial biopsy considered if abnormal uterine bleeding occurs. The Endocrine Society guideline is available at endocrine.org.

Standard monitoring parameters for women on Prometrium 200 mg/day (cyclic) or 100 mg/day (continuous):

• Blood pressure: measured at each visit
• Breast exam: annually, with mammography per USPSTF schedule (biennial for ages 50-74, or per individualized decision for ages 40-49)
• Uterine bleeding diary: kept by the patient; any unscheduled bleeding triggers endometrial assessment
• Liver function tests: not routinely required for oral micronized progesterone unless hepatic disease is present

For veterans with a history of traumatic brain injury (TBI), the sedative metabolite 5-alpha-pregnanolone may produce more pronounced drowsiness. Bedtime dosing mitigates this but providers should counsel on next-morning sedation when doses exceed 200 mg. Start with 100 mg at bedtime and titrate based on tolerability over 4 to 6 weeks.